Status:
UNKNOWN
Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections
Lead Sponsor:
Benha University
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
we designed this randomized, single -blind, prospective clinical study to test postoperative analgesia of three intrathecal additives in elective caesarean sections which are magnesium, dexamethasone ...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists classII-III adult female patient (age :18 -40 years old )
- Elective cesarean section under spinal anaesthesia
- Gestational age \> 37 weeks
- BMI less than 30 kg/m2
Exclusion
- Patient refusal
- unable to give consent
- age \< 18 or \> 40
- BMI more than 30 kg/m2
- known allergy to the study medication
- coagulopathies or on anticoagulant medications
- diabetic neuropathy
- patients with psychiatric disorders
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT04747171
Start Date
April 1 2021
End Date
July 1 2021
Last Update
February 10 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.